Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma

Publisher: Karger

E-ISSN: 2296-5262|27|6|540-544

ISSN: 2296-5270

Source: Oncology Research and Treatment, Vol.27, Iss.6, 2004-12, pp. : 540-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract